We have studied the effect of hypoxia on the expression of genes encoding for lOnP1/PRss15 and cathepsins in u87 glioma cells in relation to inhibition of inositol requiring 
C
athepsins are a group of lysosomal proteases that have a key role in cellular and extracellular protein turnover as well as multiple roles in cancer and autophagy [1] [2] [3] . Cathepsin A (CTSA), also known as chaperone protective protein and protective protein for β-galactosidase, is a lysosomal carboxypeptidase present at the cell surface, endoplasmic reticulum, nucleus and secreted outside the cell, which appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and performs a protective function necessary for their stability and activity and involved in tumor progression and metastasis by degrading the extracellular matrix [3, 4] . Cathepsin A plays a significant role in the processing of endogenous bioactive peptides and is also involved in inhibition of chaperon-mediated autophagy through proteolytic processing of LAMP-2A [1, 2] . Recently it was shown that overexpression of CTSA associates with the cellular oxidative stress response [5] .
CTSB is a lysosomal cysteine proteinase, which is also present at the cell surface, nucleus and mitochondrion, implicated in tumor invasion and metastasis; toll-like receptor signaling pathway [6] . Recently it was shown that inhibition of cathepsin B activity by clioquinol-ruthenium complex impairs tumor cell invasion [7] . Extracellular matrix remode ling by cell adhesion-related processes is critical for proliferation and tissue homeostasis and the actin-binding protein, filamin A, regulates the organization and remodeling of the pericellular collagen matrix through its effects on degradation pathways, particularly MMP-9 and cathepsin B, which is nece ssary for intracellular collagen digestion [8] . Huber et al. [9] have shown that the urokinase plasminogen activator receptor strongly interacts with cysteine-rich angiogenic inducer 61 (CYR61) and the Y-box-binding protein 1(YB-1) in the triple-negative breast cancer and that both interactors significantly correlated with the expression levels of cathepsin B, c-MET and the tumor grade. In addition, expresdoi: https://doi.org/10.15407/ubj89.02.055 sion levels of CYR61 significantly correlated with cathepsin D [9] . Moreover, myeloid-derived suppressor cells are immune suppressive cells that are hallmarks of human cancer and apoptosis pathways play a key role in homeostasis of these cells through CTSB and CTSD [10] . Cathepsin B also participates in autophagy, which mediates tumor suppression via cellular senescence, particularly in TGF-β-induced autophagy [11] [12] [13] .
Increased tissue activity of cathepsin C can be observed in many pathological conditions [4] . It is associated with an enhanced degradation of glycosaminoglycans, proteoglycans, and glycoproteins, and results in their decreased tissue content. Cathep sin C releases the glycosidases from complexes formed with cathepsin A, and reinstates their activity [4] . Furthermore, CTSB, CTSC, and CTSD are increased in numerous tumors [14, 15] . Thus, human telomerase reverse transcriptase (hTERT) overexpression is responsible for the upregulation of the cysteine protease cathepsin D by regulating EGR-1 to activate invasiveness in cancer progression [15] . It is interesting to note that matrix-metalloproteinase-9 is cleaved and activated by cathepsin K [16] . Moreover, almost identical substrate specificities were determined for cysteine cathepsins K, L and S [17] . Cathepsin S also has relation to regulation of autophagy [18] .
Mitochondria play an important role in tumor progression but its functional activity is reprogrammed in cancers [19] [20] [21] . The mitochondrial Lon peptidase 1 (LONP1, also known as serine protease 15; PRSS15), is a mitochondrial matrix protein that belongs to the Lon family of ATP-dependent proteases and mediates the selective degradation of misfolded, unassembled or oxidative damaged polypeptides as well as certain short-lived regulatory proteins in the mitochondrial matrix, but not aggregated proteins [19, 22] . LONP1 may also have a chaperone function in the assembly of inner membrane protein complexes, and participate in the regulation of mitochondrial gene expression and maintenance of the integrity of the mitochondrial genome [23] . Lon peptidase 1 can be included in the growing class of proteins that are not responsible for oncogenic transformation, but that are essential for survival and proliferation of cancer cells, because it is a key enzyme controlling mitochondrial bioener getics in cancer [23, 24] . Therefore, LONP1 is an essential protein for life and that it also performs a critical function in tumorigenesis by regulating the bioenergetics of cancer cells as a central regulator of mitochondrial activity in oncogenesis [33] . Recently it was shown that inhibition of LONP1 by the anticancer molecule triterpenoid alters mitochondria and is associated with to cell death in RKO human colon cancer cells [20] . LONP1 expression is induced by various stimuli, including hypoxia and reactive oxygen species, and provides protection against cell stress [25] . Furthermore, down-regulation of this enzyme is associated with ageing and with cell senescence, while up-regulation is observed in tumor cells, and is correlated with a more aggressive phenotype of cancer [25] . Consequently, the mitochondrial Lon peptidase 1 is at the crossroads of oxidative stress, ageing and cancer. Goo et al. [26] have shown that mitochondrial proteins, LONP1 and prohibitin, are overexpressed in HTRA2(-/-) mouse embryonic fibroblast cells and HTRA2 knock-down HEK293T cells, indica ting that mitochondrial HTRA2 (hightemperature requirement A serine peptidase 2) might be an upstream regulator of mitochondrial homeostasis.
The unfolded protein response/endoplasmic reticulum stress is responsible for enhanced cancer cell proliferation and knockdown of IRE1, a major signaling pathway of endoplasmic reticulum stress, by a dominant-negative construct of IRE1 (dnIRE) resulted in a significant anti-proliferative effect on glioma growth [27] [28] [29] . The rapid growth of solid tumors generates micro-environmental changes in association with hypoxia, nutrient deprivation and acidosis, which promote neovascularisation, cell survival and proliferation [30] [31] [32] . The activation of endoplasmic reticulum stress is indispensable for tumor growth as it facilitates adaptation to stressful environmental conditions [33] . IRE1 is the most evolutionary conserved sensor that responds to protein misfolding with a highly tuned program aimed to either resolve the stress or direct the cell towards apoptosis in case stress becomes too severe, which makes it a key regulator of cell life and death processes [28, 33] . Recently, we have shown that glucose deprivation affects the expression of proliferation related genes in U87 glioma cells and that IRE1 knockdown modifies glucose deprivation effects on these genes expression possibly contributing to suppression of glioma cells proliferation [34] .
Malignant gliomas are highly aggressive tumors with very poor prognosis and to date there is no efficient treatment available. The moderate efficacy of conventional clinical approaches therefore underlines the need for new therapeutic strategies. Glucose is important substrate for glycolysis, which is important to glioma development and a more agressive behaviour [35] . A better knowledge of tumor responses to glucose deprivation condition is required to elaborate therapeutical strategies of cell sensibilization, based on the blockade of survival mechanisms [36, 37] .
The aim of this study was investigation of the effect of hypoxia on the expression of LONP1/ PRSS15 and a subset of cathepsins in glioma cells in relation to inhibition of IRE1, a major signaling enzyme of endoplasmic reticulum stress, with hopes of elucida ting its mechanistic part in the development and progression of glioma and the contribution to unfolding protein response.
materials and methods
cell lines and culture conditions. In this study we used two sublines of U87 glioma cells, which are growing in high glucose (4.5 g/l) Dulbecco's modified Eagle's minimum essential medium (DMEM; Gibco, Invitrogen, USA) supplemented with glutamine (2 mM), 10% fetal bovine serum (EquitechBio, Inc., USA), streptomycin (0.1 mg/ml; Gibco) and penicillin (100 units/ml; Gibco) at 37 °C in a 5% CO 2 incubator. One subline was obtained by selection of stable transfected clones with overexpression of vector (pcDNA3.1), which was used for creation of dominant-negative constructs (dnIRE1). This untreated subline of glioma cells (control glioma cells) was used as control 1 in the study of hypoxia effects on the expression level of lOnP1, Ctsa, Ctsb, CtsC, CtsD, CtsF, CtsK, CtsL, CtsO, and Ctss genes. The second subline was obtained by selection of stable transfected clones with overexpression of dnIRE1 and has suppressed both protein kinase and endoribonuclease activities of this bifunctional sensing and signaling enzyme of endoplasmic reticulum stress. The expression level of studied nuclear genes which encoded mitochond rial proteins in these cells was compared with cells, transfected by vector (control 1). The subline, which overexpresses dnIRE1, was also used as control 2 for investigation the effect of hypoxia condition on the expression level of studied in cells with inhibited signaling enzyme IRE1 function. Clones were received by selection at 0.8 mg/ml geneticin (G418) and grown in the presence of this antibiotic at lower concentration (0.4 mg/ ml).
In experiments with hypoxia culture plates with complete DMEM were exposed in a special chamber with 3% oxygen, 92% nitrogen, and 5% carbon dioxide for 16 hrs.
The suppression level of IRE1 both enzymatic activity in glioma cells that overexpress a dominantnegative construct of inositol requiring enzyme-1 was estimated previously [27, 38] by determining the phosphorylation of IRE1 and the expression level of XBP1 alternative splice variant (XBP1s), a key transcription factor in IRE1 signaling, using cells treated by tunicamycin (0.01 mg/ml during 2 hrs). Moreover, the proliferation rate of glioma cells with mutated IRE1 is decreased 2 fold [27, 38] . Thus, the blockade of both kinase and endoribonuclease activity of signaling enzyme IRE1 has a significant effect on proliferation rate of glioma cells.
Rna isolation. Total RNA was extracted from glioma cells as previously described [38] . The RNA pellets were washed with 75% ethanol and dissolved in nuclease-free water. For additional purification RNA samples were re-precipitated with 95% ethanol and re-dissolved again in nuclease-free water. RNA concentration and spectral characteristics were measured using NanoDrop Spectrophotometer.
Reverse transcription and quantitative PCR analysis. QuaniTect Reverse Transcription Kit (QIA-GEN, Germany) and Thermo Scientific Verso cDNA Synthesis Kit (Germany) were used for cDNA synthesis according to manufacturer's protocols. The expression level of LONP1, CTSA, CTSB, CTSC, CTSD, CTSF, CTSK, CTSL, CTSO, and CTSS mRNA were measured in glioma cell line U87 and its subline (clone 1C5) by real-time quantitative polymerase chain reaction using "RotorGene RG-3000" qPCR (Corbett Research, Germany), "7500 HT Fast Real-Time PCR System" (Applied Biosystems) or "Mx 3000P QPCR" (Stratagene, USA) and Absolute qPCR SYBRGreen Mix (Thermo Fisher Scientific, ABgene House, Epsom, Surrey, UK). Polymerase chain reaction was performed in triplicate. The amplification of cDNA of the mitochondrial lon peptidase 1 (LONP1; EC_number ="3.4.21.53"), also known as hLON ATP-dependent protease and PRSS15 (protease, serine, 15), was performed using forward primer (5′-ATCTACCTGAGCGA-CATGGG-3′) and reverse primer (5′-TTACG-GTGGGTCTGCTTGAT-3′). These oligonucleotides correspond to sequences 1111-1130 and 1304-1285 of human LONP1 cDNA (GenBank accession number NM_004793). The size of amplified fragment is 194 bp. For amplification of the cathepsin A (CTSA; EC_number="3.4.16.5), also known as chaperone protective protein and carboxypeptidase C, cDNA we used next primers: forward 5′-CAGCTGCTTC-CACCTACCTC-3′ and reverse 5′-CTTCTGGTT-GAGGGAATCCA-3′. The nucleotide sequences of these primers correspond to sequences 1432-1451 and 1682-1663 of human CTSA cDNA (GenBank accession number NM_000308). The size of amplified fragment is 251 bp. The amplification of cDNA of the cathepsin B (CTSB; EC_number="3.4.22.1") was performed using forward primer (5′-CAAGC-CACCCCAGAGAGTTA-3′) and reverse primer (5′-TAGAGGCCACCAGAAACCAG-3′). These oligonucleotides correspond to sequences 360-379 and 680-661 of human CTSB cDNA (GenBank accession number NM_001908). The size of amplified fragment is 321 bp. For amplification of the CTSC (EC_number="3.4.14.1) cDNA we used next pri mers: forward 5′-TCAGACCCCAATCCTAAGCC-3′ and reverse 5′-GCATGGAGAATCAGTGCCTG-3′. The nucleotide sequences of these primers correspond to sequences 949-968 and 1108-1089 of human CTSC cDNA (GenBank accession number NM_001814). The size of amplified fragment is 160 bp. The amplification of cDNA for the CTSD (EC_num-ber="3.4.23.5") was performed using forward primer (5′-CAAGTTCGATGGCATCCTGG-3′) and reverse primer (5′-CGGGTGACATTCAGGTAGGA-3′). These oligonucleotides correspond to sequences 712-731 and 930-911 of human CTSD cDNA (GenBank accession number NM_001909). The size of amplified fragment is 219 bp. For amplification of the CTSF (EC_number="3.4.22.41) cDNA we used next primers: forward 5′-AGGAGCTCTTG-GACTGTGAC-3′ and reverse 5′-TAGACCTTG-GCCTTCTCTGC-3′. The nucleotide sequences of these primers correspond to sequences 1052-1071 and 1217-1198 of human CTSF cDNA (GenBank accession number NM_003793). The size of amplified fragment is 166 bp. The amplification of the CTSK (EC_number="3.4.22.38) cDNA was performed using forward primer (5′-GCTCAAGGTTCTGCT-GCTAC-3′) and reverse primer (5′-TCTTCACTG-GTCATGTCCCC-3′). These oligonucleotides correspond to sequences 238-257 and 483-464 of human CTSK cDNA (GenBank accession number NM_000396). The size of amplified fragment is 246 bp. For amplification of the CTSL (EC_num-ber="3.4.22.15) cDNA we used next primers : forward 5′-ACAGCTTCACAATGGCCATG-3′ and reverse 5′-AAGCCCAACAAGAACCACAC-3′. The nucleotide sequences of these primers correspond to sequences 562 -581 and 717 -698 of human CTSL cDNA (GenBank accession number NM_001912). The size of amplified fragment is 210 bp. The amplification of the CTSO (EC_num-ber="3.4.22.42) cDNA was performed using forward primer (5′-ATTATGGCTGCAATGGAGGC-3′) and reverse primer (5′-GGGCCAAAGGTAAGAA-GTGC-3′). These oligonucleotides correspond to sequences 549-568 and 768-749 of human CTSO cDNA (GenBank accession number NM_001334). The size of amplified fragment is 220 bp. For amplification of the CTSS (EC_number="3.4.22.27) cDNA we used next primers: forward 5′-AACAA-GGGCATCGACTCAGA-3′ and reverse 5′-AA-GAAAGAAGGATGACGCGC-3′. The nucleotide sequences of these primers correspond to sequences 844-863 and 468-449 of human CTSS cDNA (GenBank accession number NM_004079). The size of amplified fragment is 197 bp. The amplification of the beta-actin (ACTB) cDNA was performed using forward 5′-GGACTTCGAGCAAGAGATGG-3′ and reverse -5′-AGCACTGTGTTGGCGTACAG-3′ primers . These primers nucleotide sequences correspond to 747-766 and 980-961 of human ACTB cDNA (GenBank accession number NM_001101). The size of amplified fragment is 234 bp. The expression of β-actin mRNA was used as control of analyzed RNA quantity. The primers were received from Sigma-Aldrich (St. Louis, MO, USA). The quality of amplification products was analyzed by melting curves and by electrophoresis using 2% agarose gel. An analysis of quantitative PCR was performed using special computer program Differen tial Expression Calculator. The values of LONP1, CTSA, CTSB, CTSC, CTSD, CTSF, CTSK, CTSL, CTSO, and CTSS mRNA expressions were normali zed to the expression of β-actin mRNA and represented as percent of control 1 (100%).
Statistical analysis. All values are expressed as mean ± SEM from triplicate measurements performed in 4 independent experiments. Statistical analysis was performed according to Student's t-test using Excel program as described previously [40] .
Results and discussion
We have studied the effect of hypoxia on the expression of genes encoding LONP1, CTSA, CTSB, CTSC, CTSD, CTSF, CTSK, CTSL, CTSO, and CTSS proteins in two sublines of U87 glioma cells in relation to inhibition of IRE1 signaling enzyme, which is a major component of the unfolded pro-tein response. It was shown that in control glioma cells (transfected by empty vector) hypoxia significantly up-regulates (+33%) the expression of gene for cathep sin A (Fig. 1) . Moreover, in cells without functional activity of IRE1 signaling enzyme the expression of this gene was not changed by hypoxia. Furthermore, inhibition of IRE1 signaling enzyme function in U87 glioma cells by dnIRE1 leads to significant up-regulation of Ctsa gene expression (+111%) upon normoxic condition in comparison with the control glioma cells (Fig. 1) .
As shown in Fig. 2 , the expression level of Ctsb gene is increased in both control glioma cells and cells with suppressed activity of IRE1 signaling enzyme upon hypoxia (+25 and +44%, correspondingly). Thus, inhibition of IRE1 enhances the effect of hypoxia on this gene expression. We also studied the effect of IRE1 inhibition on the expression of this gene in normoxic condition. It was shown that inhibition of IRE1 signaling enzyme is significantly increased (+60%) the expression level of CTSB mRNA in glioma cells upon normoxic condition as compared to control glioma cells (Fig. 2) .
Investigation of the expression of CtsC gene, which encodes cathepsin C enzyme, shown that hypoxia down-regulated the expression this gene in both control U87 glioma cells and cells with inhibited IRE1 signaling enzyme function (-53 and -54%; Fig. 3 ). Next we studied the effect of inhibition of IRE1 signaling enzyme function on the expression of CtsC gene in normoxic condition: the level of CTSC mRNA expression is down-regulated (almost in 3 fold) in glioma cells without IRE1 enzyme function in comparison with the control glioma cells.
We next investigated the effect of hypoxia on the expression of CtsD gene in control U87 glioma 
Fig. 3. Effect of hypoxia on the expression level of cathepsin C (CtsC) mRna in control u87 glioma cells stable transfected with vector (vector) and cells with inhibited function of signaling enzyme iRE1 (dniRE1) measured by qPCR. values of CtsC mRna expressions were normalized to β-actin mRna and represented as percent of control 1 (100%); mean ± sEM; n = 4

Fig. 4. Effect of hypoxia on the expression level of cathepsin D (CtsD) mRna in control u87 glioma cells stable transfected with vector (vector) and cells with inhibited function of signaling enzyme iRE1 (dniRE1) measured by qPCR. values of CtsD mRna expressions were normalized to β-actin mRna and represented as percent of control 1 (100%); mean ± sEM; n = 4
glioma cells (-17%).
Thus, the effect of hypoxia on this gene expression is significantly reduced in glioma cells with suppressed IRE1 function. Furthermore, the expression of this gene is strongly up-regulated in normoxic condition by inhibition of signaling enzyme IRE1 (+208%) as compared to control glioma cells.
As shown in Fig. 5 , the expression level of CTSF mRNA is increased in both control glioma cells and cells with suppressed activity of IRE1 signa ling enzyme upon hypoxia (+52 and +19%, correspondingly). Thus, inhibition of IRE1 significantly reduces the effect of hypoxia on this gene expression. We also studied the effect of IRE1 inhibition on the expression of CtsF gene in normoxic condition and showed that inhibition of IRE1 signaling enzyme strongly increased (+134%) the expression level of this gene in glioma cells as compared to control glioma cells (Fig. 5) .
Investigation of the expression of Ctsk gene, which encodes cathepsin K enzyme, showed that hypoxia up-regulated the expression of this gene in both control U87 glioma cells and cells with inhibited IRE1 signaling enzyme function (+43 and +28%; Fig. 6 ). Next we studied the effect of inhibition of IRE1 signaling enzyme function on the expression of Ctsk gene in normoxic condition: the level of this mRNA expression is slightly down-regulated (-15%) in glioma cells without IRE1 enzyme function in comparison with the control glioma cells (Fig. 6 ).
As shown in Fig. 7 , the expression level of CTSL mRNA is decreased in both control glioma cells and cells with suppressed activity of IRE1 signaling enzyme upon hypoxia (-16 and -26%, correspondingly). Thus, inhibition of IRE1 significantly reduces the effect of hypoxia on this gene expression. We also studied the effect of IRE1 inhibition on the expression of Ctsl gene in normoxic condition and it was shown that inhibition of IRE1 signaling enzyme strongly decreased (-66%) the expression level of this gene in glioma cells as compared to control glioma cells (Fig. 7) .
We next investigated the effect of hypoxia on the expression of CtsO gene in control U87 glioma cells and cells with inhibited function of signa ling enzyme IRE1. As shown in Fig. 8 , the expression level of CTSO mRNA is down-regulated (-33%) in control glioma cells treated by hypoxia. In cells with suppressed function of IRE1 the hypoxia also decreased the level of CTSO mRNA expression in comparison with the control 2 glioma cells (-31%). Thus, the effect of hypoxia on this gene expression is significantly reduced in glioma cells with suppressed IRE1 function. Furthermore, the expression of this gene is strongly up-regulated in normoxic condition by inhibition of signaling enzyme IRE1 (+85%) as compared to control glioma cells (Fig. 8) .
Investigation of the expression of Ctss gene, which encodes cathepsin S enzyme, showed that hypoxia down-regulated the expression this gene in control U87 glioma cells and up-regulated cells with inhibi ted IRE1 signaling enzyme function (-17 and +86%; Fig. 9 ). Next we studied the effect of inhibition of IRE1 signaling enzyme function on the expression of Ctss gene in normoxic condition: the level of this mRNA expression is strongly down-regu lated (-93%) in glioma cells without IRE1 enzyme function in comparison with the control glioma cells (Fig. 9) . As shown in Fig. 10 , the expression level of LONP1/PRSS15 mRNA is increased in control glioma cells (+52%). Cells with suppressed activity of IRE1 signaling enzyme were resistant to hypoxia. Thus, inhibition of IRE1 removed the effect of hypoxia on this gene expression. We also studied the effect of IRE1 inhibition on the expression of LONP1 gene in normoxic condition. We revealed that inhibition of IRE1 signaling enzyme in glioma cells has slightly decreased the expression level of this gene (-20%) as compared to control glioma cells (Fig. 10) .
Fig. 7. Effect of hypoxia on the expression level of cathepsin l (Ctsl) mRna in control u87 glioma cells stable transfected with vector (vector) and cells with inhibited function of signaling enzyme iRE1
Therefore, the effect of hypoxia on the expression level of genes encoding all studied cathepsins as well as mitochondrial lon peptidase 1 is dependent on IRE1 signaling enzyme function, because inhibition of IRE1 significantly modifies hypoxic regulation of these gene expressions: removes the effect of hypoxia on Ctsa, and lOnP1 genes, introduces reverse changes on CtsD and Ctss genes, reduceson CtsF and Ctsk genes, and increases sensitivity to hypoxia of Ctsb and Ctsl genes ( Fig. 11 and  12) . Therefore, hypoxia affected the expression level of most studied genes in relation to the functional activity of IRE1 enzyme, a central mediator of endoplasmic reticulum stress, which control cell proliferation and tumor growth.
In this study we have shown that hypoxia significantly affects the expression of most studied genes encoding cathepsins and LONP1 in U87 glioma cells and that inhibition of IRE1 signaling enzyme function modifies the effect of hypoxia on the expression level of these genes in gene specific manner like many other previously studied endoplasmic reticulum stress responsive genes, including nuclear genes for numerous mitochondrial proteins [33, 39, [41] [42] [43] [44] [45] .
Results of this study clearly demonstrate that the expression of cathepsin A and B, which have [1, 2, 6, 12] , is also increased in control glioma cells upon hypoxia, but the knockdown of IRE1 signaling enzyme in glioma cells removes the sensitivity of Ctsa gene expression to hypoxia and enhances this sensitivity for Ctsb gene. It is possible that the regulation of Ctsa and Ctsb genes expression by hypoxia is mediated by IRE1 and blockade of this signaling enzyme function modifies the sensitivity of the expression of these genes to hypoxia. Thus, our results that inhibition of IRE1 via overexpression of dnIRE1 removes the sensitivity of the expression of Ctsa gene to hypoxia agree well with functional role of this protease and suppression of glioma cell proliferation [1, 2, 5] . It is interesting to note that overexpression of chaperone protective protein CTSA is associated with the cellular oxidative stress response [5] and involved in tumor progression and metastasis by degrading the extracellular matrix [3, 4] . Hypoxia also induced the expression level of CtsD, CtsF, and Ctsk in control glioma cells, but the expression of CtsC, Ctsl, CtsO, and Ctss is down-regulated by hypoxia in these glioma cells. At the same time, inhibition of IRE1 had diverse effect on the sensitivity of these genes expression to hypoxia. It is possible that all these cathepsins participate in many pathological conditions and most of them are implicated in tumor invasion, metastasis, and autophagy [4, 15, 16, 18, 46, 47] . Moreover, almost identical substrate specificities were determined for cysteine cathepsins K, L and S, but almost all cathepsins have specific functions and consequently diverse changes upon hypoxia [17, 48] .
LONP1 have variable functions and increased level of this gene transcript in control glioma cells upon hypoxia can be responsible for selective degradation of misfolded and certain short-lived regulatory proteins in the mitochondrial matrix, which should be induced by hypoxia [20] . At the same time, the IRE1 signaling enzyme knockdown in glioma cells completely removes the sensitivity of lOnP1 gene expression to hypoxia. It is possible that the regulation of this gene expression by hypoxia is mediated by IRE1 and blockade of this signaling enzyme function affects the sensitivity of lOnP1 gene expression to hypoxia. Thus, the increased expression of the LONP1 gene upon hypoxia is agreed well with functional role of this protease [22, 23] . Therefore, LONP1 protease is an essential enzyme for life and plays a critical function in tumorigenesis by regulating the bioenergetics of cancer cells as a central regulator of mitochondrial activity in oncogenesis [20] . Furthermore, the expression of this mitochondrial protease is induced by various stimuli, including hypoxia and reactive oxygen species, and possibly provides protection against cell stress [25] .
In conclusion, our results demonstrate that all genes studied are responsive to hypoxia in IRE1 dependent manner and potentially contribute to regulation of cell proliferation, metastasis, and apoptosis through various signaling pathways and stress related transcription, but the mechanisms and functional significance of activation of their expressions through IRE1 inhibition as well as hypoxia are different and warrant further investigation. Thus, the changes observed in the studied genes expression partially agree with slower proliferation rate of glioma cells harboring dnIRE1, attesting to the fact that targeting the unfolded protein response is viable, perspective approach in the development of cancer therapeutics [27, 38, [49] [50] [51] .
However, the functional significance of changes in lOnP1, Ctsa, Ctsb, CtsC, CtsD, CtsF, Ctsk, Ctsl, CtsO, and Ctss gene expressions upon hypoxia and inhibition of IRE1 signaling enzyme function is still unclear and more research are needed. Вивчено вплив гіпоксії на експресію ядер-них генів, що кодують катепсини та LONP1/ PRSS15 у клітинах гліоми лінії U87 в умовах пригнічення залежного від інозитолу ензиму 1 (IRE1). Показано, що гіпоксія збільшувала експресію генів Ctsa, CtsB, CtsD, CtsF, Ctsk та lOnP1 і знижувала експресію генів CtsC, Ctsl, CtsO та Ctss у контрольних (трансфікованих вектором без вставки) клітин гліоми. Пригнічення функції сигнального ен-зиму IRE1 у цих клітинах змінювало ефект гіпоксії на експресію більшості досліджених генів: знімало ефект гіпоксії на експресію генів Ctsa та lOnP1, міняло напрям змін на експресію генів CtsD та Ctss, послаблювало -на експресію генів CtsF та Ctsk і посилювало -на експресію генів Ctsb та Ctsl. Таким чином, гіпоксія змінювала рівень експресії більшості досліджених генів залежно від функціональної активності ензиму IRE1, центрального медіатору стресу ендоплазматичного ретикулума, який контролює проліферацію клітин та ріст пухлин.
К л ю ч о в і с л о в а: гіпоксія, експресія мРНК, катепсини, LONP1, пригнічення IRE1, клітини гліоми лінії U87. Изучено влияние гипоксии на экспрессию генов, кодирующих катепсины и LONP1/PRSS15 в клетках глиомы линии U87 при угнетении за-висимого от инозитола энзима (IRE1). Показа-но, что гипоксия увеличивала экспрессию ге-нов Ctsa, Ctsb, CtsD, CtsF, Ctsk и lOnP1 и снижала экспрессию генов CtsC, Ctsl, CtsO и Ctss в контрольных (трансфецированных век-тором без вставки) клетках глиомы. Угнетение функции сигнального энзима IRE1 в этих клет-ках изменяло эффект гипоксии на экспрессию большинства исследованных генов: снимало эффект гипоксии на экспрессию генов Ctsa и lOnP1, меняло направление изменений на экс-прессию генов CtsD и Ctss, ослабляло -на экс-прессию генов CtsF и Ctsk и усиливало -на экспрессию генов Ctsb и Ctsl. Таким образом, гипоксия изменяла уровень экспрессии боль-шинства исследованных генов в зависимости от функциональной активности энзима IRE1, цен-трального медиатора стресса эндоплазматиче-ского ретикулума, который контролирует про-лиферацию клеток и рост опухолей. К л ю ч е в ы е с л о в а: гипоксия, экспрес-сия мРНК, катепсины, LONP1, угнетение IRE1, клетки глиомы линии U87.
